Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 3
1997 5
1998 7
1999 7
2000 6
2001 11
2002 11
2003 11
2004 10
2005 6
2006 10
2007 15
2008 19
2009 15
2010 7
2011 18
2012 24
2013 16
2014 9
2015 2
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

197 results
Results by year
Filters applied: . Clear all
Page 1
The mutational landscape of lethal castration-resistant prostate cancer.
Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, Quist MJ, Jing X, Lonigro RJ, Brenner JC, Asangani IA, Ateeq B, Chun SY, Siddiqui J, Sam L, Anstett M, Mehra R, Prensner JR, Palanisamy N, Ryslik GA, Vandin F, Raphael BJ, Kunju LP, Rhodes DR, Pienta KJ, Chinnaiyan AM, Tomlins SA. Grasso CS, et al. Nature. 2012 Jul 12;487(7406):239-43. doi: 10.1038/nature11125. Nature. 2012. PMID: 22722839 Free PMC article.
The landscape of long noncoding RNAs in the human transcriptome.
Iyer MK, Niknafs YS, Malik R, Singhal U, Sahu A, Hosono Y, Barrette TR, Prensner JR, Evans JR, Zhao S, Poliakov A, Cao X, Dhanasekaran SM, Wu YM, Robinson DR, Beer DG, Feng FY, Iyer HK, Chinnaiyan AM. Iyer MK, et al. Nat Genet. 2015 Mar;47(3):199-208. doi: 10.1038/ng.3192. Epub 2015 Jan 19. Nat Genet. 2015. PMID: 25599403 Free PMC article.
Germline mutations in HOXB13 and prostate-cancer risk.
Ewing CM, Ray AM, Lange EM, Zuhlke KA, Robbins CM, Tembe WD, Wiley KE, Isaacs SD, Johng D, Wang Y, Bizon C, Yan G, Gielzak M, Partin AW, Shanmugam V, Izatt T, Sinari S, Craig DW, Zheng SL, Walsh PC, Montie JE, Xu J, Carpten JD, Isaacs WB, Cooney KA. Ewing CM, et al. N Engl J Med. 2012 Jan 12;366(2):141-9. doi: 10.1056/NEJMoa1110000. N Engl J Med. 2012. PMID: 22236224 Free PMC article.
Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets.
Beltran H, Rickman DS, Park K, Chae SS, Sboner A, MacDonald TY, Wang Y, Sheikh KL, Terry S, Tagawa ST, Dhir R, Nelson JB, de la Taille A, Allory Y, Gerstein MB, Perner S, Pienta KJ, Chinnaiyan AM, Wang Y, Collins CC, Gleave ME, Demichelis F, Nanus DM, Rubin MA. Beltran H, et al. Cancer Discov. 2011 Nov;1(6):487-95. doi: 10.1158/2159-8290.CD-11-0130. Cancer Discov. 2011. PMID: 22389870 Free PMC article.
Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer.
Pienta KJ. Pienta KJ. Semin Oncol. 2001 Aug;28(4 Suppl 15):3-7. doi: 10.1016/s0093-7754(01)90148-4. Semin Oncol. 2001. PMID: 11685722 Review.
Prostate cancer in young men: an important clinical entity.
Salinas CA, Tsodikov A, Ishak-Howard M, Cooney KA. Salinas CA, et al. Nat Rev Urol. 2014 Jun;11(6):317-23. doi: 10.1038/nrurol.2014.91. Epub 2014 May 13. Nat Rev Urol. 2014. PMID: 24818853 Free PMC article. Review.
Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth.
Zhang J, Lu Y, Pienta KJ. Zhang J, et al. J Natl Cancer Inst. 2010 Apr 21;102(8):522-8. doi: 10.1093/jnci/djq044. Epub 2010 Mar 16. J Natl Cancer Inst. 2010. PMID: 20233997 Free PMC article. Review.
Molecular markers of prostate cancer.
Bradford TJ, Tomlins SA, Wang X, Chinnaiyan AM. Bradford TJ, et al. Urol Oncol. 2006 Nov-Dec;24(6):538-51. doi: 10.1016/j.urolonc.2006.07.004. Urol Oncol. 2006. PMID: 17138135 Review.
Cancer stem cells and their role in metastasis.
Shiozawa Y, Nie B, Pienta KJ, Morgan TM, Taichman RS. Shiozawa Y, et al. Pharmacol Ther. 2013 May;138(2):285-93. doi: 10.1016/j.pharmthera.2013.01.014. Epub 2013 Feb 4. Pharmacol Ther. 2013. PMID: 23384596 Free PMC article. Review.
Prostate cancer biomarkers: a current perspective.
Kumar-Sinha C, Rhodes DR, Yu J, Chinnaiyan AM. Kumar-Sinha C, et al. Expert Rev Mol Diagn. 2003 Jul;3(4):459-70. doi: 10.1586/14737159.3.4.459. Expert Rev Mol Diagn. 2003. PMID: 12877385 Review.
197 results
Jump to page
Feedback